7 articles tagged with #equity-research. AI-curated summaries with sentiment analysis and key takeaways from 50+ sources.
TD Cowen has initiated coverage on three public Bitcoin treasury companies and classified the sector as a legitimate investable equity category. The firm simultaneously issued a price target of approximately $140,000 for Bitcoin in 2026, signaling institutional confidence in both the asset and the emerging corporate treasury strategy.
Evercore ISI has initiated coverage of Credo Technology with an outperform rating and a $325 price target, reflecting analyst confidence in the company's AI connectivity solutions. The coverage highlights significant growth potential in the AI infrastructure sector, though market volatility and valuation risks present challenges to the stock's trajectory.
JPMorgan elevated UnitedHealth's price target to $466 following a strong Q1 earnings beat and improved medical care ratio, driving the stock to 52-week highs with gains exceeding 20% in 2026. The analyst upgrade reflects confidence in the healthcare company's operational improvements and financial momentum.
Bank of America upgraded ON Semiconductor to Buy with an $85 price target, citing strength in AI-related power solutions and the Treo product line. The upgrade reflects confidence in ON's positioning within the AI semiconductor supply chain, backed by a $6 billion three-year buyback commitment.
Goldman Sachs upgraded Porsche (P911) stock to Buy with a €59 price target, implying 23% upside potential. The upgrade reflects analyst confidence in the automaker's pricing power and cost optimization strategies, driving a market rally in the stock.
CAVA stock jumped 7% following a UBS analyst upgrade to Buy with a $90 price target, supported by strong same-store sales momentum and management's aggressive expansion plans targeting 75+ new locations in 2026.
Bernstein has reaffirmed an outperform rating on AstraZeneca (AZN), identifying its non-oncology portfolio as significantly undervalued with 37% upside potential to a £186 price target. The stock gained 3.1% on the analyst note, suggesting market recognition of hidden value in overlooked business segments.
